1-4 of 4
Martin Gore
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma

Victoria L. Bridgeman, Elaine Wan, Shane Foo, Mark R. Nathan, Jonathan C. Welti, Sophia Frentzas, Peter B. Vermeulen, Natasha Preece, Caroline J. Springer, Thomas Powles, Paul D. Nathan, James Larkin, Martin Gore, Naveen S. Vasudev, Andrew R. Reynolds
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2016) 15 (1): 172–183.
https://doi.org/10.1158/1535-7163.MCT-15-0170
Published: 07 January 2016
View article titled, Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
Open the PDF for Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

The Association of PI3 Kinase Signaling and Chemoresistance in Advanced Ovarian Cancer

Craig P. Carden, Adam Stewart, Parames Thavasu, Emma Kipps, Lorna Pope, Mateus Crespo, Susana Miranda, Gerhardt Attard, Michelle D. Garrett, Paul A. Clarke, Paul Workman, Johann S. de Bono, Martin Gore, Stan B Kaye, Udai Banerji
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (7): 1609–1617.
https://doi.org/10.1158/1535-7163.MCT-11-0996
Published: 05 July 2012
View article titled, The Association of PI3 Kinase Signaling and Chemoresistance in Advanced Ovarian Cancer
Open the PDF for The Association of PI3 Kinase Signaling and Chemoresistance in Advanced Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B242: A phase I/II study of oncolytic reovirus plus chemotherapy (carboplatin/paclitaxel) in patients with advanced solid tumors (with emphasis on patients with squamous cell carcinoma of the head and neck (SCCHN)

Kevin J. Harrington, Eleni M. Karapanagiotou, Pandha Hardev, Christopher M. Nutting, Martin Gore, Mettinger Karl, Hall Geoff, Alan Melcher, Ball Mercel, Matt Coffey, Brad Thompson, John Chester
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B242.
https://doi.org/10.1158/1535-7163.TARG-09-B242
Published: 10 December 2009
View article titled, Abstract B242: A phase I/II study of oncolytic reovirus plus chemotherapy (carboplatin/paclitaxel) in patients with advanced solid tumors (with emphasis on patients with squamous cell carcinoma of the head and neck (SCCHN)
Journal Articles

p53 therapy in a patient with Li-Fraumeni syndrome

Neil Senzer, John Nemunaitis, Michael Nemunaitis, Jeffrey Lamont, Martin Gore, Hani Gabra, Rosalind Eeles, Nayanta Sodha, Frank J. Lynch, Louis A. Zumstein, Kerstin B. Menander, Robert E. Sobol, Sunil Chada
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (5): 1478–1482.
https://doi.org/10.1158/1535-7163.MCT-07-0125
Published: 18 May 2007
View article titled, <em>p53</em> therapy in a patient with Li-Fraumeni syndrome
Open the PDF for <em>p53</em> therapy in a patient with Li-Fraumeni syndrome in another window